<DOC>
	<DOCNO>NCT02893631</DOCNO>
	<brief_summary>Stroke treatment include thrombolysis , thrombectomy patient proximal artery occlusion sometimes neurosurgery . It rise question regard hemostasis : thrombolysis induces fibrinolysis effect coagulation , fibrinogen platelet duration effect unknown . Thus management antithrombotics hemostasis thrombectomy surgery issue . Objectives : describe thrombolysis-induced hemostatic disorder ( fibrinolysis , coagulation , fibrinogen , platelet ) patient require thrombectomy stroke evaluate time require normalization disorder . Methods : Observational monocentric study include rtPA-treated patient require endovascular treatment stroke . Blood sample within first 48 hour rtPA administration ass fibrinolysis , coagulation platelet function point care device specific laboratory test . Record clinical biological data .</brief_summary>
	<brief_title>Assessment Hemostasis Disorders rtPA-treated Patients Requiring Endovascular Treatment Ischemic Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Hemostatics</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>patient 18 treatment rtPA acute stroke endovascular treatment require opposition participate study long term anticoagulanttreated patient pregnant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>